Capabilities

We identify the global marketing potential and requirements for commercial success for novel therapeutics & gene therapies from pre-clinical to PIII that target rare and ultra rare diseases.  Establishing target product profile(s) for major markets in which assets will compete, defining target audiences, forecasting, and informing clinical development plans to address market needs.

We conduct qualitative and quantitative market research to achieve a comprehensive understanding of the market environment and disease burden. Shape value proposition creation and supporting messages based on clinical and economic evidence for rare & ultra rare therapeutics to address the needs of payers and decision makers across healthcare systems in the U.S. and globally.

As your interim Commercial Team, we build the foundational elements of your evidence based go-to-market plan in a cost-effective way. Inclusive of brand plan development (i.e., patient journey, segmentation, targeting, positioning, competitive assessment) and translation of strategy to executable elements across media channels in preparation for product launch.